NP Life Sciences Health Industry Group Inc. (ACAT): Cash & Equivalents
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$70.6K
As of 2023-12-31
-15.9%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $70.6K | -42.1% | 2024-04-16, Balance as of period end |
| 2022-12-31 | $121.9K | +335.4% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $28.0K | -76.4% | 2023-04-18, Balance as of period end |
| 2020-12-31 | $118.6K | -51.2% | 2022-04-15, Balance as of period end |
| 2019-12-31 | $242.9K | n/a | 2021-04-15, Balance as of period end |